Peritoneal dialysis cycler with disinfection
By converting fluid transport components to reusable parts and separating fresh and used fluid paths for sterilization and disinfection, the dialysis machine addresses the challenges of disposable waste and cost in automated peritoneal dialysis systems, improving convenience and reducing environmental impact.
Patent Information
- Application Number
- JP2024527358
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-11
- Filing Date
- 2022-11-07
- Publication Date
- 2024-11-21
AI Technical Summary
Existing dialysis machines, particularly automated peritoneal dialysis systems, are cumbersome due to the use of disposable items that are expensive, generate waste, and require significant setup time and effort, while also being prone to errors during handling and disposal.
The system converts the majority of fluid transport components into reusable parts that are disinfected after treatment, using a single reusable PD fluid pump and separating fresh and used fluid paths for sterilization and disinfection, reducing the need for disposable items and minimizing waste.
This approach simplifies fluid control, reduces waste, and lowers costs by reusing components, while ensuring effective sterilization and disinfection of the dialysis machine, thereby enhancing patient convenience and reducing environmental impact.
Smart Images

Figure 2024543380000001_ABST
Abstract
Description
[Technical field]
[0001] (CROSS REFERENCE TO PRIORITY CLAIM AND RELATED APPLICATIONS) This application claims priority to and the benefit of U.S. Provisional Patent Application No. 63 / 278,290, entitled "Peritoneal Dialysis Cycler with Disinfection," filed November 11, 2021, the entire contents of which are incorporated herein by reference.
[0002] FIELD OF THE DISCLOSURE The present disclosure relates generally to medical fluid therapy, and more particularly to dialysis fluid therapy. [Background technology]
[0003] Due to various causes, the renal system may fail. Renal failure results in several physiological disturbances: It is no longer possible to balance water and minerals and to excrete the daily metabolic load. Toxic end products of metabolism such as urea, creatinine, uric acid, etc. may accumulate in the patient's blood and tissues.
[0004] Reduced kidney function, especially kidney failure, is treated by dialysis, which removes waste products, toxins and excess water from the body that normally functioning kidneys would remove. Dialysis treatments for kidney replacement are vital for many people, as the treatment is life-threatening.
[0005] One type of renal failure therapy is hemodialysis ("HD"), which generally uses diffusion to remove waste products from a patient's blood. Diffusion occurs because of a diffusion gradient across a semi-permeable dialyzer between the blood and an electrolyte solution called the dialysate or dialysis fluid.
[0006] Hemofiltration ("HF") is an alternative renal replacement therapy that relies on convective transport of toxins from the patient's blood. HF is achieved by adding replacement or substitution fluid to the extracorporeal circuit during treatment. The replacement fluid, and fluid accumulated by the patient between treatments, is ultrafiltered during HF treatment, providing a convective transport mechanism that is particularly useful for removing middle and large molecules.
[0007] Hemodiafiltration ("HDF") is a treatment modality that combines convective and diffusive clearance. HDF, like standard hemodialysis, uses dialysis fluid flowing through a dialyzer to provide diffusive clearance. In addition, replacement solution is delivered directly to the extracorporeal circuit to provide convective clearance.
[0008] Most HD, HF, and HDF treatments are performed in facilities. Home hemodialysis ("HHD") exists today. In part, HHD can be performed daily, providing therapeutic benefits over in-center hemodialysis treatments, which are typically performed twice or three times a week. Studies have shown that more frequent treatments remove more toxins and waste products and have less interdialytic fluid overload than patients receiving less frequent but perhaps longer treatments. Patients receiving more frequent treatments do not experience as many down cycles (fluid and toxin fluctuations) as in-center patients who build up two or three days' worth of toxins before treatment. In certain areas, the nearest dialysis facility may be many miles away from the patient's home, causing door-to-door treatment times to consume a large portion of the day. Treatments at facilities closer to the patient's home may also consume a large portion of the patient's day. HHD can be performed at night or during the day, when the patient is relaxing, working, or otherwise productive.
[0009] Continuous renal replacement therapy ("CRRT") is a blood therapy like HD, HF and HDF, but instead is performed in an acute setting, such as a hospital, where the patient may be experiencing renal failure due to external causes that place the patient in the hospital. Because the patient is likely to be in the hospital for an extended period of time, CRRT can be performed more slowly than typical chronic HD therapy. CRRT therapy generally uses bags of dialysis fluid (HD) or replacement fluid (HF and HDF), and is thus like peritoneal dialysis, the aspects of which are discussed next (although certain HHD systems have also used bagged dialysis fluid). However, CRRT therapy is a blood therapy that may be performed using HD tubing configurations (commonly in the United States) or HF or HDF tubing configurations (commonly in Europe).
[0010] Another type of renal failure therapy mentioned above is peritoneal dialysis ("PD"), in which dialysis solution, also called dialysis fluid, is infused into the patient's peritoneal cavity via a catheter. The dialysis fluid is in contact with the peritoneal membrane within the patient's peritoneal cavity. Waste, toxins and excess water enter the dialysis fluid from the patient's bloodstream through capillaries in the peritoneum by diffusion and osmosis, i.e., an osmotic gradient is created across the membrane. An osmotic agent in the PD dialysis fluid provides the osmotic pressure gradient. Spent or exhausted dialysis fluid is pumped out of the patient, removing the waste, toxins and excess water from the patient. This cycle is repeated, for example, multiple times.
[0011] There are various types of peritoneal dialysis therapies, including continuous ambulatory peritoneal dialysis ("CAPD"), automated peritoneal dialysis ("APD"), tidal flow dialysis, and continuous flow peritoneal dialysis ("CFPD"). CAPD is a manual dialysis treatment, in which the patient manually connects an implanted catheter to a drain to allow used or spent dialysis fluid to drain from the peritoneal cavity. The patient then switches the fluid communication so that the patient catheter communicates with a bag of fresh dialysis fluid to infuse fresh dialysis fluid through the catheter and into the patient. The patient disconnects the catheter from the fresh dialysis fluid bag, allowing the dialysis fluid to remain in the peritoneal cavity, and transfer of waste, toxins, and excess water occurs. After a dwell period, the patient repeats the manual dialysis procedure, for example, four times a day. Manual peritoneal dialysis requires significant patient time and effort and leaves significant room for improvement.
[0012] Automated peritoneal dialysis ("APD") is similar to CAPD in that the dialysis treatment includes drain, fill, and dwell cycles. However, APD machines typically perform the cycles automatically while the patient sleeps. APD machines relieve the patient from having to manually perform the treatment cycles and from having to transport supplements during the day. APD machines fluidly connect to an implanted catheter, a source or bag of fresh dialysis fluid, and a fluid drain. The APD machine pumps fresh dialysis fluid from the dialysis fluid source through the catheter and into the patient's peritoneal cavity. APD machines also allow the dialysis fluid to dwell in a chamber where waste, toxins, and excess water can be transported. The source may contain multiple liters of dialysis fluid, including several solution bags.
[0013] APD machines pump used or spent dialysate from the patient's peritoneal cavity through a catheter to a drain. As with the manual process, several drain, fill and dwell cycles occur during dialysis. A "final fill" may occur at the end of an APD treatment. The final fill fluid may remain in the patient's peritoneal cavity until the start of the next treatment, or it may be manually emptied at some point during the day.
[0014] In any of the above modalities using automated machines, fluid control is very important as such control controls the flow of fresh and spent dialysis fluid to and from the patient. One HD machine provided by the assignee of the present disclosure controls the flow of fluid provided by a fresh PD fluid pump and a spent PD fluid pump. A flow sensor is provided for each PD fluid pump. By drawing somewhat more spent dialysis fluid from the dialysis machine than the fresh dialysis fluid delivered to the dialysis machine as measured by the flow sensor, a desired amount of patient ultrafiltration ("UF") is achieved. Although the control method works well, the flow sensors can be expensive.
[0015] In any of the above therapies using automated machines, the automated machines usually operate with disposable sets that are discarded after one use. Depending on the complexity of the disposable set, the cost of using one set per day can be large. Daily disposables also require space for storage, which can be troublesome for homeowners and businesses. In addition, disposable sets can generate large amounts of hard and soft plastic waste. Furthermore, daily disposable replacement requires daily set-up time and effort by the patient or caregiver at home or in the clinic.
[0016] For each of the above reasons, it would be desirable to provide an automated dialysis machine (blood and PD) that simplifies the control of the flow of fresh and spent dialysis fluid and reduces disposable waste. Summary of the Invention [Means for solving the problem]
[0017] Known automated peritoneal dialysis ("PD") systems typically include a machine or cycler that accepts and operates a pumping cassette having a rigid portion and a soft portion that is deformable to perform pumping and valving operations. The rigid portion is attached to tubing that extends to various bags. The disposable cassette, and associated tubing and bags, can be cumbersome for the patient or caregiver to load for treatment. The amount of disposable items can lead to multiple set-up procedures and expose opportunities for error. The disposable items are expensive and cumbersome to dispose of as previously discussed.
[0018] On the other hand, the automated PD system and associated methodology of the present disclosure converts most of the fluid-carrying parts of the PD system into reusable components that are disinfected after treatment. Fluid lines in the machine or cycler are reused. Remaining disposable items may include patient and drain lines, dialysis fluid containers or bags, and solution lines. If not connected to a fluid container or bag, or an online dialysis fluid generation source, the reusable dialysis fluid line may be connected to a dedicated disinfection connector or to itself. In either embodiment, the reconnected dialysis fluid line forms a disinfection loop, which allows for disinfection after treatment. It is contemplated to use either water or remaining dialysis fluid as the disinfecting fluid and heat it to a disinfection temperature, e.g., 65°C or 75°C to 130°C. The flow components, lines and tubing to be disinfected may be metal, e.g., stainless steel, or plastic, e.g., polyvinyl chloride ("PVC"), or non-PVC materials such as polyethylene ("PE"), polyurethane ("PU"), or polycarbonate ("PC").
[0019] Within the housing of the machine or cycler, reusable tubing lines run through one or more dialysis fluid line valves. In one embodiment, any of the valves of the PD machine may be electrically actuated solenoid valves with a reusable valve body that either prevents PD fluid from flowing through the valve body (e.g., when no power is applied) or allows PD fluid to flow through the valve body (e.g., when power is applied). In one embodiment, first and second dialysis fluid in-line heaters may also be provided and electrically actuated. One of the in-line heaters is used to heat the treatment fluid, e.g., a resistive heater with a reusable heater body that receives the PD fluid for heating. The in-line heater in an embodiment may heat the PD fluid from room temperature to body temperature, e.g., 37° C., at a flow rate of at least 300 milliliters ("ml") / min. One or more temperature sensors may be located adjacent to, e.g., downstream of, the heater to provide feedback for temperature control. Since this PD machine separates the fresh PD fluid side from the used PD fluid side, specifically for post-treatment disinfection / sterilization, a second heater is provided to disinfect the used PD fluid side of the PD machine. The second heater may be of the first type and may have the same capabilities as the first heater. The first treatment fluid heater is additionally used after treatment to sterilize the fresh PD fluid side of the PD machine.
[0020] The machine embodiments discussed herein include a single reusable PD fluid pump, such as a precision volumetric pump. The reusable pump includes a reusable pump body that accepts the spent PD fluid for pumping. That is, the pump does not require the dialysis fluid to flow in a disposable item such as a tube or cassette. The reusable volumetric PD fluid pump can be an electric piston, membrane or gear pump that can be precise in nature. The PD fluid pump, in one embodiment, is bidirectional and continuous. The PD fluid pump, in one embodiment, is positioned in the spent PD fluid path such that the pump pumps the spent PD fluid back and forth between two volume balancing chambers to force the fresh PD fluid to a desired location during patient fill. That is, the PD fluid pump using the spent PD fluid draws fresh PD fluid into the volume balancing chamber and expels fresh PD fluid from the volume balancing chamber. The PD fluid pump also pumps the spent PD fluid from the patient to the drain during patient drain.
[0021] Each of the volume balancing chambers includes a well-defined volume chamber separated by a membrane or diaphragm. The diaphragm can bend back and forth in the chamber to expel a volume of fluid, e.g., fresh PD fluid, by receiving an equal volume of spent fluid on the other side of the diaphragm. The volume balancing chambers allow a single PD fluid pump to be used. The single PD fluid pump pumps into each of the volume balancing chambers as determined by the state of the associated valves. The valves are sequentially arranged to direct fresh or spent PD fluid to or from the volume balancing chambers, and to allow fresh or spent dialysis fluid to be delivered from the chambers to the patient or to the drain. The volume balancing chambers also perform a monitoring task in that their known volume output can be used to verify that the stroke volume of the piston pump does not change over time.
[0022] Certain embodiments discussed herein also include one or more air traps for trapping air removed from the PD fluid and for providing a bolus or buffer of dialysis fluid. The air traps may also participate in a disinfection sequence at the end of treatment. The air traps may be located, for example, in the fresh PD fluid line and the used PD fluid line. A vent valve may be provided from the top of the air trap, which may be used during a disinfection sequence, for example, to vent air from the air trap to the atmosphere. In one embodiment, one or more level sensors are located adjacent to each air trap to maintain a desired level or range of levels of fresh and used PD fluid in the air trap.
[0023] Each of the embodiments discussed herein may also include one or more pressure sensors for detecting the pressure of the fresh and spent PD fluid. The pressure sensors output positive and negative patient pumping pressure signals that are used to ensure that patient pumping pressure limits are not exceeded. Because the spent PD fluid is used to drive the fresh PD fluid, one or more pressure sensors may be provided in the spent PD fluid path, for example on the negative side of the volume balancing chamber, and monitored to control the resulting positive fresh PD fluid pumping pressure. Optionally, one or more temperature compensated conductivity sensors may also be provided for evaluation of the spent PD fluid.
[0024] The disclosed PD machine or cycler includes a control unit having one or more processors and one or more memories that receive signals or outputs from the pressure sensor, one or more temperature sensors, and the conductivity sensor and process the signals or outputs as feedback. The control unit uses the pressure feedback to control the PD fluid pump to pump at safe pressure limits during treatment and at safe system limits during disinfection. The control unit uses the temperature feedback to control the dialysis fluid heater to heat fresh dialysis fluid, for example to body temperature. The control unit counts strokes performed by the volumetric equilibration chamber and also determines the total amount of fresh dialysis fluid delivered to the patient. The control unit monitors the PD fluid pump and determines the total amount of spent dialysis fluid removed from the patient. The control unit compares the amounts and also determines the total amount of ultrafiltration ("UF") removed from the patient.
[0025] The control unit also sequences the volume equilibration chambers in combination with the operation of the PD fluid pumps to perform priming sequences, treatment sequences, and post-treatment "germ deactivation" sequences by opening and closing the dialysis fluid valves. The control unit powers the heaters during treatment and disinfection sequences.
[0026] The two sides of the volumetric equilibration chamber (fresh vs. used) are completely separated from each other (including the disinfection mode of the present disclosure). Thus, the two different sides can be "clean" after treatment using different approaches, e.g., sterilization of the fresh side and disinfection of the drain side. One important advantage of separating the flow paths as done in the present disclosure is that the most "sensitive" flow path components (pumps, pressure sensors, conductivity cells, etc.) that experience the lowest temperatures during "sterilization" (a term used herein to include either or both sterilization or disinfection) can be positioned on the used PD fluid side. This results in a longer life or number of operations for the flow path components. The division allows the fresh PD flow path to be significantly minimized, minimizing the amount of actual sterilization required.
[0027] It is also contemplated that the disinfection temperature on the spent PD fluid side of the flow path may be maintained at a lower value than that used in today's dialysis machines. Today, some machines use a maximum temperature during the disinfection cycle of about 85° C. The heating sequence in prior art machines is about 37 minutes, resulting in an A0 disinfection value of about 1440 (the requirement is to exceed 900). For the APD cycler of the present disclosure, the disinfection time can be extended and the disinfection temperature can be lowered, still allowing to achieve an A0 value of more than 900. In one example, assuming a flow path volume of 100-150 ml, heating the spent PD fluid flow path to 75° C. means that an A0 disinfection value of 900 can be achieved within about 47 minutes. If a shorter disinfection time is required, for example performed immediately before a treatment, a disinfection temperature of 85° C. or higher may be used instead.
[0028] Sterilization of the fresh side of the volumetric equilibration chamber in one embodiment requires reaching a sterilization grade temperature, e.g., a fluid temperature of 120°C or higher, which is maintained for 15-20 minutes. Given the small volume of the fresh PD fluid flow path, the sterilization parameters are well achievable. Note that the fresh PD fluid path and the used PD fluid path need to be "sterilized" in sequence, and they cannot completely overlap in one embodiment. Thus, the total time for a complete "sterilization" sequence can be anywhere between one hour to one and a half hours.
[0029] In a first aspect of the present disclosure, which in light of the disclosure set forth herein is in no way limiting of the disclosure but which may be used with any other aspect or portion thereof, a peritoneal dialysis ("PD") system includes a first volume balancing chamber including a first fixed volume chamber and a first diaphragm positioned and arranged to expand back and forth within the first fixed volume chamber, the first diaphragm separating a fresh PD fluid side from a spent PD fluid side of the first volume balancing chamber; a second volume balancing chamber including a second fixed volume chamber and a second diaphragm positioned and arranged to expand back and forth within the second fixed volume chamber, the second diaphragm separating a fresh PD fluid side from a spent PD fluid side of the second volume balancing chamber; and a PD fluid pump positioned and arranged to pump spent PD fluid back and forth between the spent PD fluid sides of the first and second volume balancing chambers.
[0030] In a second aspect of the disclosure, which may be used with any other aspect or portion thereof, the PD system includes at least one valve in fluid communication with a fresh PD fluid side of one of the first or second volume balancing chambers, and when the PD fluid pump pumps spent PD fluid into the spent PD fluid side of the first or second volume balancing chamber, fresh PD fluid is discharged from the fresh PD fluid side via the at least one valve.
[0031] In a third aspect of the present disclosure, which may be used with any other aspect or portion thereof, a PD system includes a control unit configured to operate a PD fluid pump, the control unit configured to (i) monitor a pumping output of the PD fluid pump and / or (ii) determine an amount of fresh PD fluid discharged from the fresh PD fluid side of the first or second volume balancing chamber by using a known volume of the first or second fixed volume chamber.
[0032] In a fourth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a PD system includes at least one valve in fluid communication with a fresh PD fluid side of the first or second volume equalization chamber, and as the PD fluid pump pumps spent PD fluid from the spent PD fluid side of the first or second volume equalization chamber, fresh PD fluid is drawn into the fresh PD fluid side through the at least one valve.
[0033] In a fifth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the PD system is configured such that during patient drain, the PD fluid pump pumps spent PD fluid through the patient line, through one of the first or second volume equalization chambers, and through the drain line.
[0034] In a sixth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a PD fluid pump pumps used PD fluid through a return lumen of a patient line, the patient line further including an output lumen for delivering fresh PD fluid to the patient.
[0035] In a seventh aspect of the present disclosure, which may be used with any other aspect or a portion thereof, a PD system includes a control unit configured to operate a PD fluid pump during a patient drain, the control unit configured to determine an amount of spent PD fluid removed into the patient drain by monitoring at least one pumping output of the PD fluid pump.
[0036] In an eighth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a PD system includes a first heater in fluid communication with a fresh PD fluid side of the first and second volume equilibration chambers and a second heater in fluid communication with a used PD fluid side of the first and second volume equilibration chambers, the first heater being used in a sterilization sequence and the second heater being used in a disinfection sequence.
[0037] In a ninth aspect of the present disclosure, which may be used in conjunction with any other aspect or a portion thereof, the first heater is further used to heat fresh PD fluid for treatment.
[0038] In a tenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a first heater heats fresh PD fluid to at least 120°C for a sterilization sequence, and a second heater heats fresh or used PD fluid to at least 65°C for a disinfection sequence.
[0039] In an eleventh aspect of the present disclosure, which may be used with any other aspect or portion thereof, a PD system includes a sterile loop including fresh PD fluid sides of first and second volume equilibration chambers and at least one of (i) at least one reusable solution line, or (ii) at least one sealing cover that covers and closes at least one patient line port and / or drain line port.
[0040] In a twelfth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a PD system includes a disinfection loop including a spent PD fluid side of first and second volume equilibration chambers and at least one sealing cover that covers and closes at least one patient line port and / or drain line port.
[0041] In a thirteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the PD system is configured to perform a patient drain in which (i) the first and second volume equalization chambers are bypassed and the accuracy of the PD fluid pump is relied upon, or (ii) the first and second volume equalization chambers are operated.
[0042] In a fourteenth aspect of the present disclosure that may be used with any other aspect or portion thereof, a peritoneal dialysis ("PD") system includes a first volume equalization chamber including a first fixed volume chamber and a first diaphragm positioned and arranged to expand back and forth within the first fixed volume chamber, the first diaphragm separating a fresh PD fluid side from a spent PD fluid side of the first volume equalization chamber; a second fixed volume chamber and a second diaphragm positioned and arranged to expand back and forth within the second fixed volume chamber. a second volume balance chamber including a diaphragm separating a fresh PD fluid side from a spent PD fluid side of the second volume balance chamber; a first heater in fluid communication with the fresh PD fluid sides of the first and second volume balancing chambers, and a second heater in fluid communication with the spent PD fluid sides of the first and second volume balancing chambers, the first heater being used in a sterilization sequence and the second heater being used in a disinfection sequence.
[0043] In a fifteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, a PD system includes a sterile loop including fresh PD fluid sides of first and second volume equilibration chambers and at least one of (i) at least one reusable solution line, or (ii) at least one sealing cover that covers and closes at least one patient line port and / or drain line port.
[0044] In a sixteenth aspect of the present disclosure that may be used with any other aspect or portion thereof, a PD system includes a disinfection loop including a spent PD fluid side of first and second volume equilibration chambers and at least one sealing cover that covers and closes at least one patient line port and / or drain line port.
[0045] In a seventeenth aspect of the present disclosure, which may be used with any other aspect or a portion thereof, a peritoneal dialysis ("PD") system includes a sterile loop including a fresh PD fluid side of a PD machine, a disinfection loop including a used PD fluid side of the PD fluid machine, and a control unit configured to perform a sterilization sequence in the sterile loop and a disinfection sequence in the disinfection loop.
[0046] In an eighteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the sterilization loop includes a fresh PD fluid side of at least one volume equilibration chamber, and the disinfection loop includes a used PD fluid side of at least one volume equilibration chamber.
[0047] In a nineteenth aspect of the present disclosure, which may be used with any other aspect or portion thereof, the disinfection loop includes at least one reusable solution line, and the disinfection loop includes at least one sealing cover that covers and closes at least one patient line port and / or drain line port.
[0048] In a twentieth aspect of the present disclosure, which may be used in conjunction with any other aspect or portion thereof, any of the features, functions, and alternatives described in association with any one or more of Figures 1 to 5 may be combined with any of the features, functions, and alternatives described in association with any other of Figures 1 to 5.
[0049] In light of the above aspects and the disclosure described herein, it is an advantage of the present disclosure to provide a PD fluid machine and associated systems that reuse many components that may otherwise be disposable.
[0050] Another advantage of the present disclosure is that it provides fluid handling components that receive dialysis fluid directly without the need to operate with disposable items such as tubing or flexible sheets.
[0051] A further advantage of the present disclosure is that it provides most of the fluid handling components on the spent PD fluid side of the PD fluid machine where the components only need to be subjected to disinfection temperatures (less than sterilization temperatures) after treatment.
[0052] Yet another advantage of the present disclosure is providing a single positive displacement pump that can be used to pump both fresh and spent PD fluid.
[0053] Yet another advantage of the present disclosure is to provide a PD machine and associated systems that require only a small amount to be sterilized.
[0054] Yet another advantage of the present disclosure is to provide a dialysis fluid machine and associated systems in which residual therapy fluid may be used during disinfection.
[0055] Further features and advantages will be described in and will be apparent from the following detailed description and drawings. The features and advantages described herein are not all-inclusive, and many further features and advantages will be apparent to those skilled in the art, particularly upon consideration of the drawings and description. Also, it is not necessary for any particular embodiment to have all the advantages described herein, and it is expressly contemplated that each advantageous embodiment may be separately claimed. Furthermore, it should be noted that the language used in this specification has been selected primarily for ease of reading and explanation purposes, and is not intended to limit the scope of the inventive subject matter. [Brief description of the drawings]
[0056] [Figure 1] FIG. 1 is a schematic diagram of one embodiment of a peritoneal dialysis ("PD") machine and associated system having a single pump located on the spent PD fluid side of the machine.
[0057] [Diagram 2] FIG. 2 is a schematic diagram of an embodiment of the PD machine and associated system of FIG. 1 in a sterilization / disinfection mode to perform "sanitization."
[0058] [Diagram 3] FIG. 3 is a schematic diagram of another embodiment of a peritoneal dialysis ("PD") machine and associated system having a single pump located on the spent PD fluid side of the machine.
[0059] [Figure 4] FIG. 4 is a schematic diagram of a third embodiment of a peritoneal dialysis ("PD") machine and associated system having a single pump located on the spent PD fluid side of the machine.
[0060] [Diagram 5] FIG. 5 is a schematic diagram of a third embodiment of a peritoneal dialysis ("PD") machine and associated system having a single pump located on the spent PD fluid side of the machine. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0061] Referring now to the drawings, and in particular to FIG. 1, the presently disclosed peritoneal dialysis ("PD") system 10a and associated methodology includes a PD machine 20a. The system 10a and PD machine 20a (as well as other systems and machines or cyclers described herein) attempt to eliminate disposable items as much as possible and instead provide most of its fluid carrying parts as reusable components, which are disinfected after treatment. The PD machine 20a includes a housing 22 that holds the reusable flow components and tubing or lines described herein. Any of the housing and reusable flow components and lines discussed herein can be made of metal, such as stainless steel, steel (for non-fluid contacting components) or aluminum (for non-fluid contacting components), or plastic, such as polyvinyl chloride ("PVC") or non-PVC materials, such as polyethylene ("PE"), polyetherketone ("PEEK"), polyurethane ("PU") or polycarbonate ("PC").
[0062] The PD machine 20a includes a PD fluid pump 24, such as a motorized piston, membrane or gear pump, which may be precise in nature. The PD machine 20a in the illustrated embodiment includes two heaters 26a and 26b, such as in-line heaters. The heater 26a, which is a treatment fluid heater, can heat the PD fluid from room temperature or lower to body temperature (e.g., 37° C.) at a flow rate of at least 300 milliliters ("ml") / min (typical PD fill and drain flow rates are 200 to 300 ml / min). Both heaters 26a and 26b are used for "sterilization" (a term used herein that includes either or both of sterilization or disinfection) at the end of treatment. The heater 26a is used for sterilization, and the heater 26b is used for disinfection. Sterilization requires higher temperatures, as discussed herein. Both heaters 26a and 26b can obtain sterilization temperatures and can be the same or different heaters with the same or different capabilities.
[0063] The PD machine 20a includes multiple valves 28a-28o, which may be electrically actuated solenoid valves with reusable valve bodies that either prevent dialysis fluid from flowing through the valve body (e.g., when no power is applied) or allow dialysis fluid to flow through the valve body (e.g., when power is applied). Valves 28a-28d are solution or supply valves. Valves 28e-28i are fresh dialysis fluid inlet / outlet valves. Valves 28j-28m are spent dialysis fluid inlet / outlet valves. Valves 28n and 28o are toggle valves that allow spent dialysis fluid to be pumped back and forth between the volumetric equilibration chambers 40a, 40b. Valves 28n and 28o may also be used when the system 10a detects air in the pump chamber. Like valve 28h, toggle valves 28n and 28o are three-way valves that switch the position or orientation of the flow path when electrically actuated.
[0064] Although not shown in the system 10a of Figure 1, one or more air traps can be provided that operate in conjunction with one or more level sensors located adjacent the air traps so that a desired level or range of levels of fresh or used PD fluid can be maintained in the air traps. The level sensors can be ultrasonic, capacitive, inductive or optical sensors that can distinguish fresh or used PD fluid from air in the air trap.
[0065] The PD machine 20a further includes temperature sensors 36a and 36b located adjacent to the in-line heaters 26a and 26b, respectively. In the illustrated embodiment, the temperature sensors 36a and 36b are located downstream of the heaters 26a and 26b. A third and fourth temperature sensor may be located upstream of the heaters 26a and 26b. The output from the temperature sensors 36a and 36b is used as feedback to control the amount of power provided to the inlet heaters 26a and 26b when fresh or used PD fluid is flowing through the inlet heaters 26a and 26b.
[0066] The dialysis machine 20a also includes a number of pressure sensors 34a-34c. The outputs from the pressure sensors 34a-34c are used to ensure that pumping of fresh PD fluid to the patient is performed within safe positive pressure limits, e.g., 1-5 psig (e.g., 2 psig (14 kPa)), and that pumping of spent PD fluid from the patient is performed within safe negative pressure limits, e.g., -1.0 psig to -3.0 psig (e.g., -1.3 psig (-9 kPa)). Each of the pressure sensors 34a-34c is shown as being on the spent PD fluid side of the PD machine 20a, which is advantageous for maximizing observation of post-treatment disinfection temperatures (as opposed to higher sterilization temperatures). Nevertheless, the outputs from the pressure sensors 34a and 34b associated with the volumetric equilibration chambers 40a and 40b, respectively, can be used to control and monitor the positive fresh PD fluid pumping pressure, as the spent PD fluid is used to drive the fresh PD fluid. The pressure of the spent PD drive fluid is converted to, and therefore is the same as, the driven fresh PD fluid.
[0067] The PD machine 20a further includes at least one conductivity sensor 38 that may be temperature compensated. In FIG. 1, the conductivity sensor 38 is shown positioned to sense the used PD fluid, and its output may be used to assess the effectiveness of the PD treatment and / or look for disease, such as peritonitis. The conductivity sensor 38 may also be used to measure the conductivity of fresh PD fluid to ensure that the fluid matches the prescribed PD fluid, for example in a priming scenario. Locating the conductivity sensor 38 on the used PD fluid side of the PD machine 20a is also advantageous in that the conductivity sensor only needs to observe the disinfection temperature after treatment.
[0068] The PD machine 20a of the system 10a includes a control unit 50 having one or more processors 52, one or more memories 54, and a video controller 56, which controls a display device 58 associated with a user interface 60 of the machine. The control unit 50 controls each of the PD fluid pump 24, the in-line heaters 26a, 26b, and the valves 28a-28o according to the flow sequences described herein. The control unit 50 also receives outputs from the level sensors (described below), pressure sensors 34a-34c, temperature sensors 36a, 36b, and one or more conductivity sensors 38, and uses those outputs for feedback purposes described herein, as well as for any readout desired on the display device 58.
[0069] The user interface 60 may include a touch screen overlay operable with the display device 58 and / or one or more electromechanical buttons, such as membrane switches, for inputting user commands. The user interface 60 may also include one or more speakers for displaying information to a user on the display device 58 and outputting alarms, alerts, and / or voice guidance commands. The user interface 60 may be provided with the PD machine 20a as shown in FIG. 1 and / or may be a remote user interface operating with the control unit 50. The control unit 50 may include a transceiver (not shown) and a wired or wireless connection to a network, e.g., the Internet, for transmitting treatment data to and receiving prescription orders from a physician or clinician server that interfaces with a physician or clinician's computer.
[0070] The volume equalization chambers 40a and 40b are passive components in that they do not receive electrical input and are not under direct control by the control unit 50. Instead, the volume equalization chambers 40a and 40b are operated via fluid pressure as directed by their associated valves. Each of the volume equalization chambers 40a and 40b includes a fixed volume chamber 42, which may be made of any medically safe material discussed herein. The fixed volume chamber 42 includes a flexible diaphragm or membrane 44 that receives a volume of used PD and expels an equal volume of fresh PD fluid by flexing back and forth. The flexible diaphragm or membrane 44 may be made of a durable, medically safe rubber, such as silicone, that does not permanently deform over multiple uses.
[0071] The housing 22 of the PD machine 20a includes several features provided to assist in the "sterilization" (sterilization and disinfection) that occurs after a treatment. The housing 22 includes, for example, spring-loaded doors 30a-30c that cover the reusable solution lines 102a-102c after a treatment when the reusable solution lines 102a-102c are disconnected from the disposable pigtails 104a-104c that extend from the PD fluid containers 106a-106c, respectively. As shown in FIG. 2, when the reusable solution lines 102a-102c are disconnected, they plug into sterilization ports 32a-32c provided in the housing 22.
[0072] The housing 22 also includes an output port 46a that receives the output lumen 108a of the patient line 108. The housing 22 further includes a return port 46b that receives the return lumen 108b of the patient line 108. The housing 22 further includes a drain port 46c that receives the drain line 112. Each of the ports 46a-46c is covered with a seal cover 48 (e.g., spring closed over the ports 46a-46c) when the patient line 108 and the drain line 112 are removed. The seal cover 48 helps return the sterile fluid (port 46a) and the disinfectant fluid (ports 46b and 46c) to the PD machine 20a, thereby forming a sterile loop and a disinfectant loop, respectively.
[0073] In the embodiment shown herein, the output lumen 108a is provided with a sterile, sterilizing grade filter 110 that provides a final level of sterilization to the fresh PD fluid before it is delivered to the patient via the patient line 108. The pore size of the sterile, sterilizing grade filter 110 may be, for example, 0.1 to 0.2 microns. A suitable sterile, sterilizing grade filter may be, for example, a Pall IV-5 or GVS Speedflow filter. Assuming the fresh PD fluid side of the system 10a is properly sterilized, it is envisioned that the sterilizing grade filter 110 will not ultimately be needed or provided. It is envisioned that a sterilizing grade filter 110 may possibly be provided until it is proven that proper sterilization is achievable and a filter is not required.
[0074] As shown in Figures 1-5, the valves that are shaded are open, while the valves that are not shaded are closed. Figure 1 shows a first PD machine 20a operating as part of a system 10a, which also includes all disposable items such as PD fluid containers 106a-106c and their pigtails 104a-104c, patient line 108 (including sterile, sterilizing grade filter 110, if provided), and drain line 112. In any of the systems of Figures 1-5, the patient may begin treatment filled with effluent from a previous treatment, or may be empty, as shown in Figures 1-5. The control unit 50 of the PD machine 20a (and any of the PD machines discussed herein) may be programmed to begin treatment by applying negative pressure to the patient. If the patient has no effluent PD fluid to give, the patient is likely empty, but instead the patient line 108 may be kinked, which may be found or repaired by raising an alarm or attempting to clear the blockage, respectively. The machine 20a may also be configured to check whether the patient's fluid status is different than expected (e.g., perhaps the patient skipped a fill on a prescribed day). The control unit 50 may also be configured to initially attempt to push a small amount of PD fluid towards the patient to determine if a kink or other line obstruction is present. If a kink is not present, the control unit 50 proceeds to the next programmed action. If a kink is present, the control unit 50 causes the user interface 60 to issue an alarm.
[0075] If the patient is full of effluent at the start of treatment, the PD machine 20a (and any of the PD machines described herein) senses this by having the PD fluid pump 24 attempt to draw effluent from the patient through the patient line 108 and return lumen 108b. If it does not sense resistance to the negative pressure, the control unit 50 determines that the patient is full of effluent and continues the initial drain. Now, the control unit 50 causes the PD fluid pump 24 to continue drawing effluent from the patient through the patient line 108 and return lumen 108b, through three-way valve 28n (for example), and causes the PD fluid pump 24 to push the effluent through three-way valve 28o, through the spent PD fluid side of the effluent or volume balancing chamber 40b, through valves 28k and 28l, through drain port 46c, through drain line 112, and into a drain container or house drain (e.g., a toilet or bathtub). In the patient drain embodiment described above, since the volume equalization chambers 40a and 40b are bypassed, the PD fluid pump 24 needs to be a precision pump, such as a piston pump.
[0076] In one embodiment, the accuracy of the PD fluid pump 24 is relied upon to know how much effluent has been removed during a patient drain (initial and subsequent drains). The PD fluid pump 24 may be, for example, a piston pump that pumps a precise amount of effluent per piston stroke. The control unit 50 accumulates the number of piston strokes over the course of multiple patient drains. A patient drain may end when at least a minimum prescribed amount of effluent has been removed from the patient. A patient drain may alternatively end when the control unit 50 receives a characteristic pressure signal indicating that the patient is empty or substantially empty. The pressure signal to the control unit 50 may be from any one or more of the pressure sensors 34a-34c.
[0077] Instead, an alternative drain flow path through at least one volume equilibration chamber may be used. In one example, the spent PD fluid is pumped to the volume equilibration chamber 40b. The control unit opens valves 28i, 28g, 28j and 28l and closes valve 28k. The spent PD fluid may be drained from the volume equilibration chamber 40a to the drain line 112. In the next half cycle, the volume equilibration chamber 40b is initially filled with patient effluent and the volume equilibration chamber 40a is initially empty. Now, the control unit 50 causes the PD fluid to pump the drained effluent towards the volume equilibration chamber 40a, which in turn pushes fresh fluid into the volume equilibration chamber 40b, causing the drained effluent to be pushed into the drain line 112 via the now open valve 28k (valve 28j is now closed). In this alternative patient drain embodiment, the PD fluid pump 24 can be a less accurate pump because the volume balancing chambers 40a and 40b are used to provide volumetric accuracy. However, it is worth noting that using a single accurate pump, such as a piston pump, is also advantageous because any errors present when determining the patient's ultrafiltration ("UF") volume, which is the difference between one or more drain volumes and one or more fill volumes, tend to cancel out. If the assumption that an accurate pump tends to error in the same manner with respect to the patient drain as with the patient's fill, is correct, the two errors will cancel out, although smaller, due to the accuracy of the pump, resulting in a more accurate UF removal volume. And it is more important for PD therapy that the UF volume is accurately determined. The volume balancing chambers 40a and 40b can be used as a monitor or primary method for determining the volume to be pumped, with the accurate pump volume used as a check.
[0078] Alternatively, if the patient is empty at the start of therapy, the control unit 50 transitions to an initial fill. Because there is no fluid in the spent PD or effluent sides of the volume equalization chambers 40a and 40b at this point, the control unit 50 instead pumps air, causing the PD fluid pump 24 to first exert a negative pressure on the flexible diaphragm 44, for example, to draw fresh PD fluid from the PD fluid container 106a into the fresh PD fluid sides of the volume equalization chambers 40a and 40b, respectively, via valves 28g and 28i. The control unit 50 then pumps air in the opposite direction, causing the PD fluid pump 24 to exert a positive air pressure on the flexible diaphragm 44 of the volume equalization chambers 40a and 40b, causing the PD fluid pump 24 to expel fresh PD fluid from the volume equalization chambers 40a and 40b. The fresh PD fluid travels through valves 28g and 28i and valves 28f and 28e to the output lumen 108a and the patient line 108. The above process (drawing fresh PD fluid into volume balancing chambers 40a and 40b and expelling it from the balancing chambers by pumping air with PD fluid pump 24) is repeated until enough fresh PD fluid is present in patient line 108 to fill the spent PD fluid or effluent side of volume balancing chambers 40a and 40b, or until there is at least enough fresh PD fluid such that PD fluid pump 24 can pump fresh PD fluid back and forth between the volume balancing chambers.
[0079] The control unit 50 then performs the first patient fill using the process described above (drawing fresh PD fluid into the volume balancing chambers 40a and 40b and draining it from the balancing chambers), but now by pumping the fresh PD fluid back and forth between the effluent sides of the volume balancing chambers 40a and 40b instead of air. The control unit 50 performs the first patient fill (and all subsequent patient fills following the fills and drains described above) by metering heated (by heater 26a under the control of the control unit 50) fresh PD fluid to the patient via the patient line 108 until the prescribed amount of fresh PD fluid is delivered. It should be understood that subsequent patient fills (any after the first patient fill) are performed after a patient drain where the effluent sides of the volume balancing chambers 40a and 40b are primed with spent PD fluid or patient effluent from the previous drain.
[0080] In an alternative embodiment, the control unit 50 causes the system 10a to be fully primed (including the fresh and spent PD fluid sides of the volume equilibration chambers 40a and 40b) before the patient connects to the PD machine 20a, where fresh PD fluid is pumped through both sides of the volume equilibration chambers 40a and 40b and eventually drained via the drain line 112.
[0081] With respect to patient fill in any of the systems and PD cyclers described herein, volume accuracy can be monitored and controlled in one or more ways. One way is discussed above with respect to patient drain, which is for the control unit 50 to count the exact pump fill strokes made by the PD fluid pump 24. That is, the amount of fluid pumped back and forth between the volume equalization chambers 40a, 40b through the three-way valves 28n and 28o must be equal to the amount of fresh heated PD fluid drained from the volume equalization chambers 40a and 40b to the patient. The other way is for the control unit 50 to count and accumulate the number of drain strokes made by each of the volume equalization chambers 40a and 40b. The volume of the fixed volume chambers 42 of the volume equalization chambers 40a and 40b is known, so that an incremental volume can be accumulated by the control unit 50 each time fresh PD fluid is drained from the chamber. Pressure sensors 34a and 34b operating in conjunction with volume equalization chambers 40a and 40b, respectively, are appropriately positioned to detect when flexible diaphragm 44 dead-ends against the wall of fixed volume chamber 42, ensuring that a full stroke of fresh PD fluid has been expelled from the fixed volume chamber. Control unit 50 may use both methods to monitor fill accuracy for comparison and / or to calibrate PD fluid pump 24 for the next patient drain where accuracy of PD fluid pump 24 is required.
[0082] 2, an exemplary "sanitization" (sterilization / disinfection) sequence of the PD machine 20a of the system 10a is shown. The teachings of the "sanitization" sequence are applicable to any of the PD machines and related systems discussed herein. Here, at the end of treatment, the patient or caregiver removes the PD fluid containers 106a-106c. The spring-loaded doors 30a-30c automatically close over the reusable solution lines 102a-102c that are sealingly plugged into the sterile ports 32a-32c, respectively. A sterile loop is thereby formed, which includes the reusable solution lines 102a-102c, the reusable lines in the PD machine 20a that lead to the fresh PD fluid sides of the volumetric equilibration chambers 40a and 40b, the fresh PD fluid sides themselves, and the output port 46a.
[0083] At the end of treatment, the patient or caregiver also removes the patient line 108 (including the output lumen 108a and the return lumen 108b) and the drain line 112 from the ports 46a-46c, respectively. The sealed cover 48, for example, springs closed over the exposed output port 46a, sealing the port and pushing the sterilizing fluid back into the sterilizing loop. The sealed cover 48 also, for example, springs closed over the exposed ports 46b-46c, sealing the port and pushing the sterilizing fluid back into the sterilizing loop, which includes the spent PD fluid or effluent side of the PD machine 20a (up to and including the spent side of the volumetric equilibration chambers 40a and 40b). The sterilizing loop at the end of treatment is filled with spent PD fluid or patient effluent, which can be used for a sterilization sequence, if desired. Alternatively, if fresh PD fluid is desired for disinfection, control unit 50 causes PD fluid pump 24 to pump the disinfection loop volume of fresh PD fluid into patient line 108 prior to its removal. Control unit 50 also causes PD fluid pump 24 to draw fresh PD fluid from patient line 108 into the disinfection loop and push spent PD fluid from the disinfection loop through drain line 112 to a drain container or house drain prior to its removal. Now, the disinfection loop or spent PD fluid side of volume equilibration chambers 40a and 40b is primed with the remaining fresh PD fluid for disinfection. Now, the sterile loop or fresh PD fluid side of volume equilibration chambers 40a and 40b is also primed with the remaining fresh PD fluid for sterilization.
[0084] In one embodiment, it does not matter which "sterilization" portion is sterilized or disinfected first. Although these two sequences may overlap, the sterilization sequence must sterilize the fresh PD fluid side of the volume equilibration chambers 40a and 40b, and the disinfection sequence must disinfect the used PD fluid side of the volume equilibration chambers. It may not be possible to sterilize and disinfect the volume equilibration chambers 40a and 40b at the same time. Furthermore, the PD fluid pump 24 is required in both the sterilization and disinfection sequences and may not be able to perform dual duties at the same time.
[0085] For sterilization, the control unit 50 may receive feedback from the temperature sensor 36a to cause the sterilization / treatment heater 26a to heat the remaining fresh PD fluid in the sterilization loop to a desired sterilization temperature, for example 120° C. or higher. The PD fluid pump 24 pumps the remaining PD fluid back and forth between the used PD fluid sides of the volume equilibration chambers 40a and 40b, causing the heated remaining PD fluid in the sterilization loop to circulate and contact and sterilize all areas of the sterilization loop. Areas of the sterilization loop that are contacted with the heated PD fluid include the reusable solution lines 102a-c, the sterilization ports 32a-c, the valves 28a-i, associated lines, the fresh PD fluid sides of the volume equilibration chambers 40a and 40b, and the output port 46a. Any one or more or all of the valves 28a-i may be switched open or closed during the sterilization sequence to aid in sterilization. The control unit 50 terminates the sterilization sequence after a sufficient F0 sterilization dose has been delivered to the sterilization loop, for example after 15 to 20 minutes of sterilization recirculation at or above 120°C.
[0086] For disinfection, which may occur before or after or overlapping the sterilization sequence, the control unit 50 receiving feedback from the temperature sensor 36b may cause the disinfection heater 26b to heat the disinfection loop fluid (e.g., remaining fresh or used PD fluid) to the desired sterilization temperature, for example 65°C or 75°C or higher.
[0087] The PD fluid pump 24 pumps the disinfection loop fluid (e.g., remaining fresh or used PD fluid) back and forth between the spent PD fluid sides of the volume equalization chambers 40a and 40b and throughout the disinfection loop, causing the heated disinfection loop fluid (e.g., remaining fresh or used PD fluid) in the disinfection loop to be circulated back and forth, contacting and disinfecting all areas of the disinfection loop. Areas of the disinfection loop that come into contact with the heated disinfection loop fluid (e.g., remaining fresh or used PD fluid) include valves 28j-28o and associated lines, the spent PD fluid sides of the volume equalization chambers 40a and 40b, and ports 46b and 46c. Any one or more or all of the valves 28j-28o may be switched open or closed (two-way) or switched between positions or orientations (three-way) during a disinfection sequence to aid in disinfection. The control unit 50 terminates the disinfection sequence after a sufficient A0 disinfection dose has been delivered to the disinfection loop, after 45 minutes (e.g., assuming a disinfection loop volume of about 100 to 150 milliliters) at 75° C. or higher. Larger or smaller disinfection loop volumes require longer and shorter disinfection times, which are primarily due to longer or shorter warm-up times associated with larger or smaller disinfection loop volumes.
[0088] 3, the PD fluid machine 20b of system 10b illustrates an alternative embodiment of the present disclosure. The PD fluid machine 20b of system 10b includes each of the features, structures, and alternatives described above with respect to the PD fluid machine 20a of system 10a. All such structures, functions, and alternatives are incorporated by reference into the PD fluid machine 20b of system 10b.
[0089] In the PD fluid machine 20a of the system 10a, air on the fresh PD fluid side and the spent PD fluid side of the system tends to collect in the volume equalization chambers 40a and 40b. The air can be detected using the pressure sensors 34a and 34b. When the amount of air in the volume equalization chambers 40a and 40b reaches a threshold, the control unit 50 causes the air to be purged to a drain container or house drain via the drain line 112 (air on the fresh PD side can be pushed to the spent PD fluid side through the return lumen 108b of the patient line 108 and discharged therefrom).
[0090] To prevent or mitigate air entering the volumetric balancing chambers 40a and 40b, the PD fluid machine 20b of the system 10b includes a fresh PD fluid air trap 62a on the fresh PD fluid side of the machine 20b and a used PD fluid air trap 62b on the used PD fluid side of the machine 20b. Each of the air traps 62a and 62b operates with one or more level sensors 64a and 64b that output to the control unit 50. The one or more level sensors 64a, 64b ensure that a desired level or range of levels of fresh and used PD fluid are maintained within the respective air traps. The level sensors 64a, 64b may be ultrasonic sensors or any other type of sensor that can detect between the PD fluid and the air.
[0091] The air traps 62a and 62b allow more air to be tolerated in the system 10b. More air can be collected before the control unit 50 needs to execute an air purge routine. When an air purge routine is required, air can also be purged from the air traps 62a and 62b during the dwell phase of therapy. In one embodiment, the air traps 62a and 62b are sized to hold the entire integral of air generated at each patient fill (air trap 62a) and each patient drain (air trap 62b) so that air purging can occur during the patient's dwell. It is the goal of the system 10b to attempt to capture air in the air traps 62a and 62b before it reaches the balance chambers 40a and 40b, which may affect their volumetric accuracy.
[0092] Referring now to FIG. 4, the PD fluid machine 20c of system 10c illustrates another alternative embodiment of the present disclosure. The PD fluid machine 20c of system 10c includes each of the features, structures, and alternatives described above with respect to the PD fluid machines 20a and 20b of systems 10a and 10b. All such structures, functions, and alternatives are incorporated by reference into the PD fluid machine 20c of system 10c. The PD fluid machine 20c of system 10c includes air traps 62a and 62b as described above with respect to the PD fluid machine 20b of system 10b. The PD fluid machine 20c of system 10c eliminates the two-way valve 28j of the PD fluid machine 20b of FIG. 3. Additionally, the two-way valve 28k of the PD fluid machine 20b of FIG. 3 is a three-way valve of the PD fluid machine 20c of FIG. 4. Thus, the PD fluid machine 20c of FIG. 4 includes one less valve than the PD fluid machine 20b of FIG. 3. It should be understood that one of ordinary skill in the art may determine many different ways to mount the valves in the PD systems of the present disclosure, and the PD fluid machine 20c of system 10c provides one example.
[0093] 5, the PD fluid machine 20d of system 10d illustrates yet another alternative embodiment of the present disclosure. The PD fluid machine 20d of system 10d includes each of the features, structures, and alternatives described above with respect to the PD fluid machines 20a-20c of systems 10a-10c, respectively. All such structures, features, and alternatives are incorporated herein by reference in the PD fluid machine 20d of system 10d. The primary difference with the PD fluid machine 20d of system 10d is the provision of alternative air traps 162a and 162b on the fresh and spent PD fluid sides, respectively, of the PD machine 20d.
[0094] One problem with air traps 62a and 62b of PD machines 20b and 20c is that they are rigid and may leak or squirt fresh or used PD fluid if there is pressure above ambient in the peripheral fluid lines and the door of PD fluid machine 20d is opened. Such pressure build-up may occur after a disinfection / sterilization stage, for example before the fluid temperature has a chance to cool. The present alternative air traps 162a and 162b alleviate the problem of pressure build-up by providing a flexible membrane 164. At the start of a "sterilization" (sterilization / disinfection) sequence, control unit 50 positions membrane 164 within air traps 162a and 162b such that there is a sufficient amount of air on the non-fluid contacting side of membrane 164. Once the "sterilization" sequence is complete, the air on the back non-fluid contacting side of membrane 164 is released via control unit 50, for example via vent valve 28p for air trap 162a and vent valve 28q for air trap 162b. The release of air from air traps 162a and 162b relieves pressure on the PD fluid in the fresh and used sides of PD machine 20c without allowing air to enter system 10d which could destroy the sterility of the fresh and used sides after sterilization / disinfection.
[0095] It should be understood that various variations and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. For example, while heat is disclosed as a mechanism for sterilization and disinfection, it should be understood that other types of disinfection, such as chemical disinfection and / or UV radiation, are alternatively or additionally possible. Accordingly, such variations and modifications are intended to be encompassed by the appended claims.
Claims
1. 1. A peritoneal dialysis ("PD") system, the PD system comprising: a first volume equilibration chamber including a first fixed volume chamber and a first diaphragm positioned and arranged to expand back and forth within the first fixed volume chamber, the first diaphragm separating a fresh PD fluid side from a spent PD fluid side of the first volume equilibration chamber; a second volume balance chamber, the second volume balance chamber including a second fixed volume chamber and a second diaphragm positioned and arranged to expand back and forth within the second fixed volume chamber, the second diaphragm separating a fresh PD fluid side from a spent PD fluid side of the second volume balance chamber; PD fluid pump and Equipped with The PD system, wherein the PD fluid pump is positioned and arranged to pump spent PD fluid back and forth between the spent PD fluid sides of the first and second volume balancing chambers.
2. 2. The PD system of claim 1, further comprising at least one valve in fluid communication with the fresh PD fluid side of one of the first or second volume equilibration chambers, wherein when the PD fluid pump pumps spent PD fluid into the spent PD fluid side of the first or second volume equilibration chamber, fresh PD fluid is discharged from the fresh PD fluid side via the at least one valve.
3. 3. The PD system of claim 2, further comprising a control unit configured to operate the PD fluid pump, the control unit configured to (i) monitor a pumping output of the PD fluid pump and / or (ii) determine an amount of fresh PD fluid discharged from the fresh PD fluid side of the first or second volume balancing chamber by using a known volume of the first or second fixed volume chamber.
4. 2. The PD system of claim 1, further comprising at least one valve in fluid communication with the fresh PD fluid side of the first or second volume equilibration chamber, wherein as the PD fluid pump pumps spent PD fluid from the spent PD fluid side of the first or second volume equilibration chamber, fresh PD fluid is drawn into the fresh PD fluid side through the at least one valve.
5. 2. The PD system of claim 1, wherein during patient drain, the PD fluid pump is configured to pump spent PD fluid through a patient line, through one of the first or second volume equalization chambers, and through a drain line.
6. 6. The PD system of claim 5, wherein the PD fluid pump pumps spent PD fluid through a return lumen of the patient line, the patient line further including an output lumen for delivering fresh PD fluid to a patient.
7. 6. The PD system of claim 5, further comprising a control unit configured to operate the PD fluid pump during patient drain, the control unit configured to determine an amount of spent PD fluid removed during the patient drain by monitoring at least one pumping output of the PD fluid pump.
8. 2. The PD system of claim 1, comprising a first heater in fluid communication with the fresh PD fluid side of the first and second volume equilibration chambers and a second heater in fluid communication with the used PD fluid side of the first and second volume equilibration chambers, the first heater being used in a sterilization sequence and the second heater being used in a disinfection sequence.
9. The PD system of claim 8 , wherein the first heater is further used to heat fresh PD fluid for treatment.
10. 9. The PD system of claim 8, wherein the first heater heats fresh PD fluid to at least 120°C for the sterilization sequence and the second heater heats fresh or used PD fluid to at least 65°C for the disinfection sequence.
11. 2. The PD system of claim 1, comprising a sterile loop including the fresh PD fluid sides of the first and second volume equilibration chambers and at least one of: (i) at least one reusable solution line; or (ii) at least one sealing cover that closes over at least one patient line port and / or drain line port.
12. 2. The PD system of claim 1, comprising a disinfection loop, the disinfection loop including the spent PD fluid side of the first and second volume equilibration chambers and at least one sealing cover that covers and closes at least one patient line port and / or drain line port.
13. 2. The PD system of claim 1, configured to perform a patient drain, in which (i) the first and second volume equalization chambers are bypassed and the accuracy of a PD fluid pump is relied upon, or (ii) the first and second volume equalization chambers are operated.
14. 1. A peritoneal dialysis ("PD") system, the PD system comprising: a first volume equilibration chamber including a first fixed volume chamber and a first diaphragm positioned and arranged to expand back and forth within the first fixed volume chamber, the first diaphragm separating a fresh PD fluid side from a spent PD fluid side of the first volume equilibration chamber; a second volume balance chamber, the second volume balance chamber including a second fixed volume chamber and a second diaphragm positioned and arranged to expand back and forth within the second fixed volume chamber, the second diaphragm separating a fresh PD fluid side from a spent PD fluid side of the second volume balance chamber; a first heater in fluid communication with the fresh PD fluid side of the first and second volume equilibration chambers, and a second heater in fluid communication with the spent PD fluid side of the first and second volume equilibration chambers; Equipped with A PD system, wherein the first heater is used in a sterilization sequence and the second heater is used in a disinfection sequence.
15. The PD system of claim 14 , wherein the first heater is further used to heat fresh PD fluid for treatment.
16. 15. The PD system of claim 14, wherein the first heater heats fresh PD fluid to at least 120°C for the sterilization sequence and the second heater heats fresh or used PD fluid to at least 65°C for the disinfection sequence.
17. 15. The PD system of claim 14, comprising a sterile loop comprising the fresh PD fluid sides of the first and second volume equilibration chambers and at least one of: (i) at least one reusable solution line, or (ii) at least one sealing cover that closes over at least one patient line port and / or drain line port.
18. 15. The PD system of claim 14, comprising a disinfection loop, the disinfection loop including the spent PD fluid side of the first and second volume equilibration chambers and at least one sealing cover that covers and closes at least one patient line port and / or drain line port.
19. 1. A peritoneal dialysis ("PD") system, the PD system comprising: a sterile loop containing the fresh PD fluid side of the PD machine; a disinfection loop including a spent PD fluid side of the PD fluid machine; a control unit configured to perform a sterilization sequence in the sterilization loop and a disinfection sequence in the disinfection loop; The PD system includes:
20. 20. The PD system of claim 19, wherein the sterilization loop comprises a fresh PD fluid side of at least one volume equilibration chamber and the disinfection loop comprises a spent PD fluid side of the at least one volume equilibration chamber.
21. 20. The PD system of claim 19, wherein the disinfection loop includes at least one reusable solution line, and the disinfection loop includes at least one sealing cover that closes over at least one patient line port and / or drain line port.
Citation Information
Patent Citations
Automatic peritoneal-dialysis apparatus
JP1994154314A
Systems and methods for performing peritoneal dialysis
JP2005533573A
Hemodialysis system
JP2020093124A
Extracorporeal dialysis ready peritoneal dialysis machine
US20090008306A1
Balanced flow dialysis machine
US20150258263A1
